Certainly looking strong, I think the statement from the company yesterday clearly states up the reality of the situation -
Once the mid cycle review comes in as positive, BOT is de-risked which equates to a more realistic valuation of the business, we go from speculation/risk on, to a risk off cash flow positive business.
The fact that SP could become a first line treatment option (after OTC) puts it miles ahead of Qbrexza.
Exciting times for share holders.
Congrats to all!
Bot Chart, page-5765
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.010(3.23%) |
Mkt cap ! $504.0M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.5¢ | 30.5¢ | $1.011M | 3.218M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 41999 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 324796 | 8 |
View Market Depth
| Last trade - 11.10am 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
31.8¢ |
Change
0.010 ( 2.68 %) |
||||
| Open | High | Low | Volume | ||
| 31.0¢ | 32.5¢ | 30.8¢ | 1612098 | ||
| Last updated 11.35am 14/06/2024 ? | |||||
| BOT (ASX) Chart |